Canopy Growth Corporation CGC Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cannabis | $53.49M+14.6% | $53.49M+14.6% | $53.49M+14.6% | $53.49M+14.6% | $46.68M-2.6% | |
| Storz And Bickel | $16.78M-14.0% | $22.89M-8.6% | $15.83M-9.9% | $15.15M-24.7% | $19.52M-36.9% | |
| Revenue (Gross) by Product | ||||||
| Canadian Adult Use Cannabis | $20.58M+0.9% | $22.93M+8.4% | $23.94M+30.2% | $27.02M+43.1% | $20.4M-2.6% | |
| Canadian Medical Cannabis | $25.28M+26.6% | $22.51M+15.0% | $21.82M+16.8% | $21.21M+12.8% | $19.97M+13.1% | |
| International Markets Cannabis | $8.6M+67.6% | $6.21M-30.8% | $5.09M-39.0% | $8.76M+4.0% | $5.13M+79.9% | |
| Storz Bickel | $16.78M-14.0% | $22.89M-8.6% | $15.83M-9.9% | $15.15M-24.7% | $19.52M-36.9% | |
| Revenue by Geography | ||||||
| CA | $46.67M+15.4% | $45.44M+11.6% | $45.76M+23.4% | $48.23M+28.0% | $40.43M+3.7% | |
| DE | $15.77M+26.7% | $19.2M+8.2% | $12.73M-10.4% | $14.38M-7.3% | $12.45M-26.4% | |
| US | $7.25M-14.4% | $8.67M-25.0% | $6.37M-13.2% | $5.97M-30.7% | $8.48M-34.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canopy Growth Corporation break its business down?
- Canopy Growth Corporation (CGC) reports revenue by business across 2 parts — Cannabis and Storz And Bickel. Each is extracted from the segment footnotes and tracked over time.
- Where does Canopy Growth Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canopy Growth Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
